Harbin Medisan Pharmaceutical Co., Ltd.

SZSE:002900.SZ

12.44 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 1,186.7861,028.414945.7991,338.8832,102.0612,172.5161,148.83760.872722.017681.521601.23491.17
Cost of Revenue 476.38365.572309.385491.301509.922351.967296.701290.049275.855287.44280.716268.529
Gross Profit 710.406662.841636.415847.5821,592.141,820.549852.129470.823446.161394.082320.514222.641
Gross Profit Ratio 0.5990.6450.6730.6330.7570.8380.7420.6190.6180.5780.5330.453
Reseach & Development Expenses 112.80689.26999.922112.019112.44879.00669.35249.03654.01650.6130.90320.816
General & Administrative Expenses 36.67125.857101.19380.51890.88419.91515.03611.67815.66514.29698.26662.76
Selling & Marketing Expenses 421.797453.909517.573605.0661,153.6181,436.069465.978132.769127.094105.70270.05340.847
SG&A 458.468479.766618.766685.5841,244.5021,455.984481.014144.447142.759119.998168.319103.607
Other Expenses 2.353110.51746.548-11.1327.156-1.8990.3317.37411.95519.9552.113-6.557
Operating Expenses 693.357679.551765.236786.4731,384.1061,604.947619.476264.476263.448226.333174.141108.499
Operating Income 79.02257.601454.80584.218228.809250.996252.708197.752186.937163.57121.413103.037
Operating Income Ratio 0.0670.0560.4810.0630.1090.1160.220.260.2590.240.2020.21
Total Other Income Expenses Net 2.353-17.531-1.95-51.061-0.58633.49520.3842.77815.2716.747-24.199-19.527
Income Before Tax 81.37440.07452.85633.157228.223249.097253.037209.126197.984174.496122.17594.615
Income Before Tax Ratio 0.0690.0390.4790.0250.1090.1150.220.2750.2740.2560.2030.193
Income Tax Expense 11.29513.567103.1786.52454.36344.71171.96233.94331.68327.51217.87714.277
Net Income 73.66330.207350.95129.325177.184205.813181.076175.183166.301146.984104.39482.717
Net Income Ratio 0.0620.0290.3710.0220.0840.0950.1580.230.230.2160.1740.168
EPS 0.240.0951.130.0950.570.650.710.740.70.630.475.3
EPS Diluted 0.240.0951.130.0950.570.650.710.740.70.630.475.3
EBITDA 198.569164.169577.688164.165304.587329.67333.89278.151241.918217.395166.593122.628
EBITDA Ratio 0.1670.160.6110.1230.1450.1520.2910.3660.3350.3190.2770.25